Viral evasion of the interferon response at a glance

J Cell Sci. 2023 Jun 15;136(12):jcs260682. doi: 10.1242/jcs.260682. Epub 2023 Jun 21.

Abstract

Re-emerging and new viral pathogens have caused significant morbidity and mortality around the world, as evidenced by the recent monkeypox, Ebola and Zika virus outbreaks and the ongoing COVID-19 pandemic. Successful viral infection relies on tactical viral strategies to derail or antagonize host innate immune defenses, in particular the production of type I interferons (IFNs) by infected cells. Viruses can thwart intracellular sensing systems that elicit IFN gene expression (that is, RIG-I-like receptors and the cGAS-STING axis) or obstruct signaling elicited by IFNs. In this Cell Science at a Glance article and the accompanying poster, we review the current knowledge about the major mechanisms employed by viruses to inhibit the activity of intracellular pattern-recognition receptors and their downstream signaling cascades leading to IFN-based antiviral host defenses. Advancing our understanding of viral immune evasion might spur unprecedented opportunities to develop new antiviral compounds or vaccines to prevent viral infectious diseases.

Keywords: Innate immunity; Interferon; Intracellular sensors; Viral evasion.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Antiviral Agents
  • COVID-19*
  • Humans
  • Immune Evasion
  • Interferon Type I*
  • Pandemics
  • Zika Virus Infection*
  • Zika Virus*

Substances

  • Antiviral Agents
  • Interferon Type I